514G3

human monoclonal antibody 514G3 · XBiotech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 514G3, covering 2024-11-21 to 2024-11-21. Get the full timeline:

Most recent: Clinical Trial Update: Safety & Efficacy of True Human Antibody, 514G3, in Staphylococcus Aureus Bacteremia Hospitalized Subjects. [Phase 1, Phase 2]

See pricing